CCNE2 and breast carcinoma: LUT may augment the impact of anticancer drugs to control breast cancer by reducing drug resistance (tamoxifen by inhibiting cyclin E2 expression), promoting apoptosis (by blocking STAT3), and inhibiting breast cancer cell growth [28,29].